Being and Integrated Nutrition Solutions (C-WINS) has enjoined stakeholders in the health sector to extend the measles-rubella vaccination campaign to the grassroots.The Head of Mission for the ...

H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The Connecticut Department of Public Health released a statement urging residents to stay up-to-date with measles ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

Despite the significant advances in poultry or waterfowl production in recent years, infectious diseases (including viral and bacterial) remain the greatest ...

Measles is one of the most contagious viral infections, capable of causing severe complications and even death, particularly ...